These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 16208731)
1. Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases. Boldron C; Van der Auwera I; Deraeve C; Gornitzka H; Wera S; Pitié M; Van Leuven F; Meunier B Chembiochem; 2005 Nov; 6(11):1976-80. PubMed ID: 16208731 [No Abstract] [Full Text] [Related]
2. Multi-target-directed ligands to combat neurodegenerative diseases. Cavalli A; Bolognesi ML; Minarini A; Rosini M; Tumiatti V; Recanatini M; Melchiorre C J Med Chem; 2008 Feb; 51(3):347-72. PubMed ID: 18181565 [No Abstract] [Full Text] [Related]
3. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease. Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767 [TBL] [Abstract][Full Text] [Related]
4. Metal ions, Alzheimer's disease and chelation therapy. Budimir A Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339 [TBL] [Abstract][Full Text] [Related]
5. Complexes of greatly enhanced thermodynamic stability and metal ion size-based selectivity, formed by the highly preorganized non-macrocyclic ligand 1,10-phenanthroline-2,9-dicarboxylic acid. A thermodynamic and crystallographic study. Melton DL; Vanderveer DG; Hancock RD Inorg Chem; 2006 Nov; 45(23):9306-14. PubMed ID: 17083230 [TBL] [Abstract][Full Text] [Related]
6. Properties of a new 4-imidazolyl derivative of a 14-membered tetraazamacrocyclic chelating agent. Nunes RM; Delgado R; Cabral MF; Costa J; Brandão P; Félix V; Goodfellow BJ Dalton Trans; 2007 Oct; (40):4536-45. PubMed ID: 17928911 [TBL] [Abstract][Full Text] [Related]
7. A simple, one-step procedure for the formation of chiral metallamacrocycles. Campbell K; Johnson CA; McDonald R; Ferguson MJ; Haley MM; Tykwinski RR Angew Chem Int Ed Engl; 2004 Nov; 43(44):5967-71. PubMed ID: 15547907 [No Abstract] [Full Text] [Related]
8. Auto-assembling of ditopic macrocyclic lanthanide chelates with transition-metal ions. Rigid multimetallic high relaxivity contrast agents for magnetic resonance imaging. Paris J; Gameiro C; Humblet V; Mohapatra PK; Jacques V; Desreux JF Inorg Chem; 2006 Jun; 45(13):5092-102. PubMed ID: 16780331 [TBL] [Abstract][Full Text] [Related]
9. Reorganizing metals: the use of chelating compounds as potential therapies for metal-related neurodegenerative disease. Badrick AC; Jones CE Curr Top Med Chem; 2011; 11(5):543-52. PubMed ID: 21189128 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. Storr T; Merkel M; Song-Zhao GX; Scott LE; Green DE; Bowen ML; Thompson KH; Patrick BO; Schugar HJ; Orvig C J Am Chem Soc; 2007 Jun; 129(23):7453-63. PubMed ID: 17511455 [TBL] [Abstract][Full Text] [Related]
11. Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy. Deraeve C; Boldron C; Maraval A; Mazarguil H; Gornitzka H; Vendier L; Pitié M; Meunier B Chemistry; 2008; 14(2):682-96. PubMed ID: 17969218 [TBL] [Abstract][Full Text] [Related]
12. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease. Robert A; Liu Y; Nguyen M; Meunier B Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460 [TBL] [Abstract][Full Text] [Related]
13. Metals ions and neurodegeneration. Molina-Holgado F; Hider RC; Gaeta A; Williams R; Francis P Biometals; 2007 Jun; 20(3-4):639-54. PubMed ID: 17294125 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of peptidic metal chelators for neuroprotection in neurodegenerative diseases. Zheng H; Youdim MB; Weiner LM; Fridkin M J Pept Res; 2005 Oct; 66(4):190-203. PubMed ID: 16138857 [TBL] [Abstract][Full Text] [Related]
15. Hydroxyquinoline based binders: promising ligands for chelatotherapy? Budimir A; Humbert N; Elhabiri M; Osinska I; Biruš M; Albrecht-Gary AM J Inorg Biochem; 2011 Mar; 105(3):490-6. PubMed ID: 20926137 [TBL] [Abstract][Full Text] [Related]
16. Structural diversity and supramolecular aggregation in calcium, strontium, and barium salicylates incorporating 1,10-phenanthroline and 4,4'-bipyridine: probing the softer side of group 2 metal ions with pyridinic ligands. Murugavel R; Korah R Inorg Chem; 2007 Dec; 46(26):11048-62. PubMed ID: 18047324 [TBL] [Abstract][Full Text] [Related]
17. "Click-to-chelate": design and incorporation of triazole-containing metal-chelating systems into biomolecules of diagnostic and therapeutic interest. Struthers H; Spingler B; Mindt TL; Schibli R Chemistry; 2008; 14(20):6173-83. PubMed ID: 18494020 [TBL] [Abstract][Full Text] [Related]
18. Thermodynamic remarks on chelating ligands for aluminium related diseases. Crisponi G; Nurchi VM J Inorg Biochem; 2011 Nov; 105(11):1518-22. PubMed ID: 22099162 [TBL] [Abstract][Full Text] [Related]